Dogwood Therapeutics DWTX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $13.23M-24.6% | $6.52M-56.1% | $10.13M+396% | $13.4M+344% | $17.54M+637% | ||
| $15M-21.7% | $8.43M-49.0% | $11.66M+410% | $14.7M+304% | $19.16M+494% | ||
| $12.54K— | $12.75K— | $15.29K— | —— | —— | ||
| $12.19M— | $12.4M— | $12.21M— | —— | —— | ||
| $67.83M— | $68.99M— | $67.92M— | —— | —— | ||
| $95.21M-1.8% | $90.17M-4.4% | $91.99M+3,929% | $96.69M+2,559% | $96.98M+2,908% | ||
| $1.99M-35.0% | $3M+42.6% | $3.47M+253% | $3.34M+356% | $3.06M+320% | ||
| $2.56M-0.8% | $3.06M-3.7% | $2.6M+94.7% | $1.89M+277% | $2.58M+353% | ||
| $14.58M+2.5% | $15.27M-49.1% | $14.61M+995% | $14.15M+2,730% | $14.24M+2,397% | ||
| $3.34K+1,649% | $2.97K+2,136% | $229+106% | $191-93.1% | $191-90.1% | ||
| -$113.06M-33.4% | -$108.08M-46.4% | -$104.3M-57.8% | -$88.55M-38.8% | -$84.74M-35.0% | ||
| $80.62M+1,038% | $74.9M+840% | $7.26M+664% | $6.88M+119% | $7.09M+167% | ||
| $95.21M-1.8% | $90.17M-4.4% | $91.99M+3,929% | $96.69M+2,559% | $96.98M+2,908% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Dogwood Therapeutics's total assets?
- Dogwood Therapeutics (DWTX) holds $95.2M in total assets, down 1.8% year over year.
- How much debt does Dogwood Therapeutics have?
- Dogwood Therapeutics carries $144.9K in total debt against $80.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Dogwood Therapeutics have?
- Dogwood Therapeutics holds $13.2M in cash and equivalents.
- Can Dogwood Therapeutics cover its short-term obligations?
- Its current ratio is 5.86 — current assets exceed current liabilities.
- Where does Dogwood Therapeutics's balance sheet data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.